Case report: Use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 3, 2012, Pages 416-418

  Lotta, Luca A ^a   Mancini, Ilaria ^a   Tuana, Giacomo ^a   Musallam, Khaled M ^a   Peyvandi, Flora ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

ADAMTS13; Clopidogrel; Drug induced thrombotic thrombocytopenic purpura; Thrombotic thrombocytopenic purpura; Ticlopidine; VWF

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; CLOPIDOGREL; CORTICOSTEROID; PREDNISONE; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CASE REPORT; CORONARY ARTERY DISEASE; DRUG ERUPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LABORATORY TEST; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; THROMBOCYTE COUNT; TREATMENT OUTCOME; WESTERN BLOTTING;

ADAM PROTEINS; AGED; AUTOANTIBODIES; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TICLOPIDINE;

EID: 84868506893     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0717-7     Document Type: Article

References (10)

1. George JN (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354:1927-1935
2. Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El-Harake MA, Raskob GE (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102:60-68
3. Sadler JE (2008) Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 112:11-18
4. Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589-600
5. Price MJ (2009) Bedside evaluation of thienopyridine antiplatelet therapy. Circulation 119:2625-2632
6. Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL (2009) Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl S20-24
7. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL (2000) Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 132:794-799
8. Camara MG, Almeda FQ (2005) Clopidogrel (Plavix) desensitization: a case series. Catheter Cardiovasc Interv 65:525-527
9. Lotta LA, Mariani M, Consonni D, Mancini I, Palla R, Maino A, Vucelic D, Pizzuti M, Mannucci PM, Peyvandi F (2010) Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura. Br J Haematol 151: 488-494
10. Lotta LA, Lombardi R, Mariani M, Lancellotti S, De Cristofaro R, Hollestelle MJ, Canciani MT, Mannucci PM, Peyvandi F (2011) Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission. J Thromb Haemost 9:1744-1751